KRAS and colorectal carcinoma: Furthermore, we propose that the mass profile from TOF‐SIMS can discriminate KRAS (Kirsten rat sarcoma 2 viral oncogene homolog) somatic mutation genotypes, of which there is a high incidence rate in CRC, >40%.20